Research Paper Volume 14, Issue 2 pp 1033—1047
Pan-cancer analysis reveals NUP37 as a prognostic biomarker correlated with the immunosuppressive microenvironment in glioma
Figure 3. Expression of NUP37 in glioma. (A) NUP37 expression in various tumor stages of glioma patients from CGGA cohort. (B) NUP37 expression in indicated IDH mutation status of glioma patients from CGGA cohort. (C) NUP37 expression in indicated 1p/19q co-deletion status of glioma patients from CGGA cohort. (D) NUP37 expression in indicated groups of glioma patients from CGGA cohort.